Sp176

MACHINE LEARNING APPLICATIONS FOR GI CANCER BIOMARKER DISCOVERY

Date
May 18, 2024

Presenter

Speaker Image for Ajay Goel
Beckman Research Institute, City of Hope Comprehensive Cancer Center

Tracks

Related Products

Thumbnail for Finding Fountains of Youth: Mechanisms of Aging and GI Cancers
Finding Fountains of Youth: Mechanisms of Aging and GI Cancers
SOCIETY: AGA Aging is associated with increased GI cancer risk but the mechanisms underlying these age related effects are incompletely understood. Better understanding of mechanisms of aging and GI carcinogenesis will enable new approaches to early detection and prevention…
Thumbnail for TISSUE-BASED TRANSCRIPTOME SIGNATURE TO PREDICT RECURRENCE AFTER LOCAL RESECTION IN T1 COLORECTAL CANCER
TISSUE-BASED TRANSCRIPTOME SIGNATURE TO PREDICT RECURRENCE AFTER LOCAL RESECTION IN T1 COLORECTAL CANCER
Background: Tumor recurrence is the event that has a major impact on survival after local resection of submucosal colorectal cancers (T1 CRC). However, currently, there are no established biomarkers to predict disease-free survival (DFS) in T1 CRC…
Thumbnail for A CIRCRNA BASED-LIQUID BIOPSY FOR NONINVASIVE AND EARLY DETECTION OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA
A CIRCRNA BASED-LIQUID BIOPSY FOR NONINVASIVE AND EARLY DETECTION OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Background: Esophageal cancer incidence and mortality are projected to increase by 58.4% and 61.8% by the end of 2040, making esophageal squamous cell carcinoma (ESCC) – the most common subtype a significant public health threat…
Thumbnail for A BLOOD-BASED EXOSOMAL MICRORNA SIGNATURE FOR SPECIFIC DIFFERENTIAL DIAGNOSIS OF INTRAHEPATIC CHOLANGIOCARCINOMA AND HEPATOCELLULAR CARCINOMA
A BLOOD-BASED EXOSOMAL MICRORNA SIGNATURE FOR SPECIFIC DIFFERENTIAL DIAGNOSIS OF INTRAHEPATIC CHOLANGIOCARCINOMA AND HEPATOCELLULAR CARCINOMA
BACKGROUND: Alcohol-associated hepatitis (AH) is the active inflammatory state of alcohol-associated liver disease (ALD). AH varies in severity from mild to severe with mortality rates reaching 30-50% in severe AH…